Atul
Atul
ChemicalsKey Fundamentals
SmallcapSpecialty ChemicalsChemicalsTapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Company is almost debt free.
Weaknesses
3- Stock is trading at 2.77 times its book value
- The company has delivered a poor sales growth of 11.0% over past five years.
- Company has a low return on equity of 9.23% over last 3 years.
Growth Rate
AI Analysis — Bull vs Bear
Atul Ltd is a diversified specialty chemicals company with a market capitalisation of about ₹17,959 crore. It trades at a P/E of 22.2x and a P/B of 2.9x, and it is almost debt free. Trailing twelve-month sales growth of 16% and profit growth of 59% show a clear recovery, but longer-term figures are weaker: 3-year ROE averages 9%, 5-year profit CAGR is 1%, and the stock's 5-year return is -8% CAGR.
- TTM compounded profit growth of 59% shows a sharp earnings recovery from the cyclical downturn in chemicals, running well above the 3-year profit CAGR of 9%.
- TTM sales growth of 16% is roughly three times the 3-year sales CAGR of 5%, which points to recovering volumes and demand across its product segments.
- The company is almost debt free, which gives it balance sheet room to fund capex and absorb cyclical swings without relying on borrowing.
- Last-year ROE of 11% is up from the 3-year average of 9%, suggesting returns are starting to move back toward the 10-year average of 13%.
- A P/E of 22.2x is modest for an Indian specialty chemicals company growing TTM profits at 59%, so part of the recovery may not yet be reflected in the valuation.
- The long-term record is steady: 10-year sales and profit CAGRs are both 9%, and the stock's 10-year CAGR is 10%, which shows the business can compound across cycles.
- The 5-year sales CAGR of 11% shows the company kept growing its top line despite industry headwinds such as Chinese dumping and destocking.
- A dividend yield of 0.49% gives a small but consistent cash return, backed by a debt-free balance sheet.
- The 3-year average ROE of 9.23% is low for a specialty chemicals company and likely near or below its cost of equity, which suggests weak capital efficiency.
- 5-year profit CAGR is only 1% while sales grew at 11% over the same period, indicating significant margin compression over the cycle.
- The stock has returned -8% CAGR over 5 years and -5% over 3 years, reflecting sustained de-rating and lagging earnings.
- A P/B of 2.87x is expensive relative to a 3-year ROE of 9%, since investors are paying close to 3x book for single-digit returns on equity.
- The 3-year sales CAGR of 5% is weak and shows how exposed the business is to chemical industry cycles and pricing pressure.
- The 59% TTM profit growth comes off a low, depressed base, so it may overstate the underlying trend if pricing or demand weakens again.
- The stock's 1-year return of 1% shows little market re-rating despite the earnings recovery, which could signal doubts about how long the improvement will last.
- A dividend yield of 0.49% is low, so shareholders depend mostly on capital appreciation, and that has been negative over 3 and 5 years.
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- ₹31.61 crore block trade flagged Sep 22
About 51,228 Atul shares changed hands on NSE at ₹6,170.50 per share, a combined ₹31.61 crore. This is a real-time signal, not a confirmed exchange-reported event, and buyer/seller identities and direction are not disclosed.
- Vinayak Deshpande joins as ID Sep 7
Shareholders used postal ballot remote e-voting to approve Vinayak Deshpande as an Independent Director for a five-year term. This is a routine governance update that adds independent oversight to the board.
TL;DR: The recent news on Atul Ltd is limited and neutral, covering one large trade and one routine board appointment. Neither item shows a clear operating or financial trigger. The ₹31.61 crore trade at ₹6,170.50 suggests institutional activity, but its direction is unknown and it has not been confirmed by the exchange. Investors should watch the official NSE/BSE bulk/block deal disclosures, the upcoming quarterly results, and chemical-sector demand and pricing trends to judge the trend from here.
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,182 | 1,194 | 1,138 | 1,212 | 1,322 | 1,393 | 1,417 | 1,452 | 1,478 | 1,552 | 1,574 | 1,670 | 1,848 |
| Expenses | 1,000 | 1,039 | 986 | 1,065 | 1,099 | 1,150 | 1,193 | 1,229 | 1,242 | 1,284 | 1,327 | 1,389 | 1,454 |
| Operating Profit | 182 | 155 | 152 | 148 | 223 | 243 | 224 | 223 | 236 | 267 | 247 | 281 | 394 |
| OPM % | 15% | 13% | 13% | 12% | 17% | 17% | 16% | 15% | 16% | 17% | 16% | 17% | 21% |
| Other Income | 10 | 24 | 17 | 16 | 16 | 35 | 19 | 50 | 28 | 50 | 40 | 92 | 35 |
| Interest | 2 | 2 | 2 | 5 | 5 | 9 | 4 | 5 | 5 | 5 | 4 | 4 | 4 |
| Depreciation | 52 | 54 | 61 | 76 | 77 | 78 | 81 | 82 | 82 | 81 | 80 | 79 | 78 |
| PBT | 138 | 124 | 105 | 83 | 158 | 191 | 158 | 186 | 177 | 231 | 203 | 289 | 347 |
| Tax % | 26% | 26% | 32% | 29% | 29% | 27% | 26% | 30% | 25% | 21% | 20% | 27% | 27% |
| Net Profit | 102 | 91 | 72 | 59 | 112 | 140 | 117 | 130 | 132 | 182 | 164 | 211 | 254 |
| EPS in Rs | 35.02 | 30.6 | 24.04 | 19.84 | 38 | 46.47 | 36.93 | 42.97 | 43.4 | 60.88 | 54.6 | 71.38 | 83.32 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,637 | 2,595 | 2,834 | 3,514 | 4,038 | 4,093 | 3,731 | 5,081 | 5,428 | 4,726 | 5,583 | 6,274 | 6,643 |
| Expenses | 2,235 | 2,134 | 2,324 | 3,008 | 3,270 | 3,191 | 2,813 | 4,168 | 4,620 | 4,086 | 4,665 | 5,240 | 5,455 |
| Operating Profit | 402 | 461 | 510 | 505 | 768 | 902 | 918 | 913 | 807 | 639 | 918 | 1,034 | 1,189 |
| OPM % | 15% | 18% | 18% | 14% | 19% | 22% | 25% | 18% | 15% | 14% | 16% | 16% | 18% |
| Other Income | 9 | 37 | 57 | 30 | 38 | 83 | 109 | 82 | 86 | 65 | 115 | 206 | 217 |
| Interest | 26 | 28 | 25 | 13 | 7 | 9 | 9 | 9 | 8 | 11 | 24 | 17 | 17 |
| Depreciation | 60 | 66 | 95 | 110 | 119 | 130 | 136 | 177 | 198 | 243 | 317 | 322 | 318 |
| PBT | 326 | 404 | 446 | 412 | 680 | 845 | 882 | 810 | 688 | 451 | 692 | 900 | 1,070 |
| Tax % | 31% | 32% | 28% | 32% | 36% | 21% | 25% | 25% | 26% | 28% | 28% | 23% | — |
| Net Profit | 240 | 274 | 323 | 281 | 436 | 671 | 660 | 605 | 507 | 324 | 499 | 689 | 811 |
| EPS in Rs | 81.13 | 92.44 | 109 | 93.21 | 146 | 225 | 222 | 204 | 174 | 110 | 164 | 230 | 270 |
| Div. Payout % | 10% | 9% | 9% | 13% | 10% | 12% | 9% | 12% | 19% | 18% | 15% | 13% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 29 | 29 | 29 |
| Reserves | 1,009 | 1,585 | 1,936 | 2,214 | 2,676 | 3,125 | 3,797 | 4,399 | 4,642 | 5,085 | 5,569 | 6,192 |
| Borrowings | 299 | 316 | 168 | 16 | 55 | 108 | 127 | 144 | 52 | 237 | 202 | 183 |
| Other Liabilities | 485 | 535 | 591 | 749 | 783 | 880 | 982 | 1,117 | 1,028 | 1,104 | 1,179 | 1,465 |
| Total Liabilities | 1,823 | 2,465 | 2,724 | 3,009 | 3,543 | 4,144 | 4,935 | 5,690 | 5,752 | 6,455 | 6,980 | 7,870 |
| Fixed Assets | 514 | 750 | 1,026 | 1,027 | 1,104 | 1,125 | 1,418 | 1,634 | 1,770 | 2,792 | 2,847 | 2,676 |
| CWIP | 112 | 180 | 59 | 96 | 172 | 368 | 250 | 420 | 1,033 | 281 | 124 | 110 |
| Investments | 66 | 382 | 429 | 470 | 752 | 1,137 | 1,361 | 1,339 | 881 | 1,392 | 1,766 | 2,592 |
| Other Assets | 1,131 | 1,154 | 1,210 | 1,415 | 1,515 | 1,513 | 1,906 | 2,297 | 2,068 | 1,990 | 2,242 | 2,492 |
| Total Assets | 1,823 | 2,465 | 2,724 | 3,009 | 3,543 | 4,144 | 4,935 | 5,690 | 5,752 | 6,455 | 6,980 | 7,870 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 306 | 401 | 392 | 356 | 404 | 881 | 718 | 231 | 707 | 667 | 603 | 1,023 |
| Investing | -167 | -375 | -175 | -129 | -408 | -782 | -645 | -163 | -469 | -683 | -494 | -891 |
| Financing | -124 | -39 | -212 | -207 | -1 | -111 | -52 | -57 | -257 | 38 | -118 | -98 |
| Net Cash Flow | 16 | -13 | 5 | 19 | -5 | -11 | 21 | 11 | -20 | 22 | -9 | 34 |
| Free Cash Flow | 111 | 31 | 180 | 213 | 195 | 508 | 396 | -359 | -167 | 164 | 334 | 851 |
| CFO/OP | 95 | 111 | 93 | 91 | 86 | 122 | 100 | 47 | 112 | 121 | 82 | 113 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 61 | 62 | 67 | 75 | 63 | 64 | 72 | 71 | 57 | 72 | 74 | 74 |
| Inventory Days | 105 | 118 | 107 | 83 | 89 | 93 | 128 | 122 | 101 | 90 | 97 | 90 |
| Days Payable | 69 | 87 | 86 | 93 | 66 | 88 | 121 | 90 | 69 | 84 | 82 | 94 |
| Cash Conversion Cycle | 97 | 93 | 88 | 66 | 86 | 69 | 78 | 103 | 89 | 77 | 89 | 70 |
| Working Capital Days | 50 | 46 | 65 | 76 | 74 | 59 | 65 | 77 | 68 | 69 | 77 | 69 |
| ROCE % | 26% | 26% | 23% | 19% | 27% | 28% | 24% | 19% | 15% | 9% | 13% | 15% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Atul insights
63 extracted metrics + investor summaries across FY04–FY27.
Documents
Frequently Asked Questions about Atul
What does Atul Ltd do?
Where is Atul Ltd (ATUL) listed?
Which sector does Atul Ltd belong to?
What is the market capitalisation of Atul Ltd?
What is the PE ratio of Atul Ltd?
What is the 52-week high and low of Atul Ltd?
Does Atul Ltd pay dividends?
What is the Return on Equity (ROE) of Atul Ltd?
Company Information
Atul Ltd. is a diversified and integrated Indian chemical company (a part of Lalbhai Group, Gujarat). The products of the company are used in various Industries and come mainly under two segments, Life Science Chemicals and Performance and Other Chemicals under 9 Businesses. [1] Since its incorporation, the company has manufactured many products for the first time in India Dyes including Vat Dyes, crop care chemicals, Phosgene, Carbamite, 2,4-D Acid, para Cresol, tissue culture raised date palms. [2]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/ATUL.md for Atul Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.